{
    "2018-05-21": [
        [
            {
                "time": "",
                "original_text": "医药生物行业投资策略报告：医药行业已进入到新一轮景气周期",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "投资策略",
                        "景气周期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“入摩”名单重磅发布 医药股或成最大赢家",
                "features": {
                    "keywords": [
                        "入摩",
                        "医药股",
                        "赢家"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "22家药企开医院：人福、益佰、康美、华润…",
                "features": {
                    "keywords": [
                        "药企",
                        "医院",
                        "人福",
                        "益佰",
                        "康美",
                        "华润"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "口服降糖药新时代开启 国内多家药企积极布局",
                "features": {
                    "keywords": [
                        "口服降糖药",
                        "新时代",
                        "药企",
                        "布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "后期配置把握三大主线：",
                "features": {
                    "keywords": [
                        "后期配置",
                        "三大主线"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "QFII早锁定47只“入摩”股 医药股数量最多",
                "features": {
                    "keywords": [
                        "QFII",
                        "入摩",
                        "医药股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "歌斐医疗基金王培俊：发掘高壁垒中容量的投资蓝海",
                "features": {
                    "keywords": [
                        "歌斐医疗基金",
                        "王培俊",
                        "高壁垒",
                        "投资蓝海"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：最大特色是稳健 要么唯一要么第一",
                "features": {
                    "keywords": [
                        "华东医药",
                        "稳健",
                        "唯一",
                        "第一"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创业25年再出发 华东医药风景这边独好",
                "features": {
                    "keywords": [
                        "创业25年",
                        "华东医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药转型元年 发力研发技术创新",
                "features": {
                    "keywords": [
                        "华东医药",
                        "转型元年",
                        "研发",
                        "技术创新"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "内分泌和免疫抑制剂双料龙头企业",
                "features": {
                    "keywords": [
                        "内分泌",
                        "免疫抑制剂",
                        "双料龙头企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业每周观点:从三个方向继续深挖医药投资机会,重点推荐万孚生物、葵花药业等优质标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "每周观点",
                        "投资机会",
                        "万孚生物",
                        "葵花药业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周观点:暂时波动不改医药行业以业绩为基础，以长期逻辑为空间的慢牛行情",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周观点",
                        "慢牛行情",
                        "业绩",
                        "长期逻辑"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}